English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 30 June 2023, 14:00 HKT/SGT
Share:
    

Source: Cure Brain Cancer Foundation
Cure Brain Cancer Foundation Unveils Fellowship Awardees
Pioneering Innovations in the Fight Against Cancer

SYDNEY, AU, June 30, 2023 - (ACN Newswire) - Cure Brain Cancer Foundation (CBCF) is pleased to announce the highly anticipated recipients of this year's prestigious Early Career Fellowships. This unrivaled funding opportunity is set to empower researchers, propelling them closer to breakthrough discoveries in the battle against brain cancer.

Designed to fuel cutting-edge research initiatives, CBCF research grants are championing advancements that hold the potential to revolutionize survival outcomes for individuals challenged by this formidable disease. From project grants to life-changing fellowships, this comprehensive program undertakes an unwavering commitment to addressing the urgent needs of the brain cancer community.

This round of CBCF grant funding is the first time ever that CBCF will be awarding two exceptional individuals: Andrew Garvie of Monash University and Dr. Alexander Davenport of Walter and Eliza Hall Medical Institute. CBCF grant monies, totaling over $1.4 million in the last 21 months, and the awarding of not one but two Early Career Fellowships in 2023, demonstrate the Foundation's commitment to supporting and empowering talented individuals in the field of cancer research.

"Today, we celebrate exceptional minds and groundbreaking projects that have the power to change lives," remarked Lance Kawaguchi, Chief Executive Officer for the Cure Brain Cancer Foundation. "These grants stand as a testament to our unwavering dedication to funding groundbreaking research that makes tangible progress in the relentless pursuit of a cure for cancer."

With this year's grant fellowship awards, innovative research initiatives will receive the vital resources they need to forge ahead with their life-saving endeavors for a duration of three years. By providing crucial funding and support for this extended period, CBCF remains at the vanguard of the fight against cancer, driving tangible impact and instilling hope in the hearts of patients and their families.

About Cure Brain Cancer Foundation

Cure Brain Cancer Foundation is an Australia-based non-profit organization that is working globally to rapidly improve disease survival through funding innovative brain cancer research. It is the largest dedicated funder of brain cancer research in Australia and has invested over $30 million into clinical trials and pre-clinical efforts across pediatric and adult brain cancers. The Foundation's mission is to unite the brain cancer community and rapidly increase patient survival and quality of life. For more information, visit https://www.curebraincancer.org.au/.

Contact Information
Melinda Koski
MK Public Relations
press@mkpublicrelations.co

Topic: Press release summary
Source: Cure Brain Cancer Foundation

Sectors: BioTech, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Changing Your Dog's Diet May Help the Planet More Than Changing Your Own, Study Finds  
Feb 11, 2026 07:00 HKT/SGT
Kincora and AngloGold Ashanti Exploration Expands and Upgrades Nevertire with Drilling Recommenced  
Feb 10, 2026 19:29 HKT/SGT
EssexBio Bolsters Commitment to Ophthalmology Innovation at APAO 2026 in Hong Kong  
Feb 10, 2026 18:14 HKT/SGT
Honda Works Partner Aston Martin Aramco Formula One(TM) Team Unveils Livery of "AMR26" F1(TM) Machine Equipped with Honda Power Unit Ahead of the 2026 Race Season  
Tuesday, February 10, 2026 5:25:00 PM
CTF Life+ Announces Winners of Financial Empowerment Case Competition, Innovative Platform Advances Intergenerational Inclusion  
Feb 10, 2026 17:02 HKT/SGT
Honda to Make Organizational Changes to Further Enhance Competitiveness its Motorcycle, Automobile and Power Products Business  
Tuesday, February 10, 2026 4:53:00 PM
KS Energy and Hitachi Collaborate on Extra-High Voltage Battery Energy Storage System  
Tuesday, February 10, 2026 1:15:00 PM
Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Designated for Priority Review in China  
Tuesday, February 10, 2026 12:34:00 PM
Spritzer EcoPark Gallops into the Year of the Horse with a Tradition-Inspired Chinese New Year Celebration  
Feb 10, 2026 11:49 HKT/SGT
Mint Signed MoU with Robotics Leader Rice Robotics to Pioneer Physical AI Solutions Across Asia  
Feb 10, 2026 09:43 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575